Combined TLR4/MyD88 scores ≥5 correlated significantly with lymph node metastasis (42.9% vs 28.3%, p=0.046) and tumor budding grade (p=0.002). The gene discussed is MYD88; the disease is metastatic malignant neoplasm in the lymph nodes.